Suppr超能文献

溶栓治疗的心肌梗死患者纤溶系统的延迟激活。冠状动脉解剖学基础的影响。

Late activation of the fibrinolytic system in myocardial infarction treated with thrombolytic therapy. Influence of the coronary anatomical substrate.

作者信息

Salvioni A, Perego G B, Marenzi G, Lauri G, Giraldi F, Grazi S, Guazzi M D

机构信息

Istituto di Cardiologia dell'Università degli Studi, Fondazione Monzino, IRCCS, Milano, Italy.

出版信息

Eur Heart J. 1996 Feb;17(2):230-6. doi: 10.1093/oxfordjournals.eurheartj.a014839.

Abstract

Procoagulant activity, thrombin and fibrinolytic system activation have been demonstrated in the first 24-48 h after acute myocardial infarction treated with thrombolytic therapy. Little is known about what happens in the subsequent days, during which the incidence of ischaemic recurrence is high. In 21 patients treated with streptokinase and in 20 patients treated with urokinase we evaluated, with multiple plasma determinations, D-dimer and fibrinogen plasma levels in the first week after myocardial infarction. From the 2nd hour after the beginning of thrombolysis to the 4th day, all patients received intravenous heparin in doses sufficient to raise the partial thromboplastin time to twice its normal level; subcutaneous calcium heparin (12,000 U/day) was subsequently substituted for the intravenous route. Coronary angiography was performed 7 days after infarction. From the basal values 2.22 +/- 1.44 nmol.1(-1) in the streptokinase group and 3.28 +/- 3.05 nmol.1(-1) in the urokinase group, D-dimer rose consistently in the 1st hour after thrombolysis 269.4 +/- 206.7 nmol.1(-1) and 44.5 +/- 35.5 nmol.1(-1) in the streptokinase and urokinase groups, respectively; P < 0.001. After the peak value, which in both groups was reached after 5 h, D-dimer slowly decreased during the study period. It reverted to normal values only in 10/21 patients in the streptokinase group; in the urokinase group normalization was attained in 14/20 patients between the 3rd and 6th days. After withdrawal of i.v. heparin in patients of both groups with TIMI 0 or 1 grade of coronary patency, D-dimer rose to levels four to seven times greater than normal; in patients of both groups with TIMI 2 or 3 grade coronary flow, D-dimer showed a monophasic pattern of progressive normalization (P < 0.05 and P < 0.01 at the 6th and 7th days, respectively, for differences between TIMI 0-1 and TIMI 2-3 groups). After myocardial infarction, thrombolysis is followed by active and persistent fibrin degradation more marked and lasting after streptokinase than after urokinase. When occurring sooner, it is a consequence of plasmin activation induced by thrombolytic agents; later it seems to be related to intracoronary substrate, as suggested by the relationship of plasma elevation of D-dimer with the presence of occluded or suboccluded infarction-related vessels.

摘要

在接受溶栓治疗的急性心肌梗死后最初24 - 48小时内,已证实有促凝血活性、凝血酶和纤溶系统激活。对于随后几天内发生的情况知之甚少,而在此期间缺血复发的发生率很高。我们对21例接受链激酶治疗的患者和20例接受尿激酶治疗的患者,在心肌梗死后第一周通过多次血浆检测评估了D - 二聚体和血浆纤维蛋白原水平。从溶栓开始后第2小时至第4天,所有患者均接受静脉肝素治疗,剂量足以使部分凝血活酶时间延长至正常水平的两倍;随后皮下注射钙肝素(12,000 U/天)替代静脉给药途径。梗死7天后进行冠状动脉造影。链激酶组的基础值为2.22±1.44 nmol·L⁻¹,尿激酶组为3.28±3.05 nmol·L⁻¹,溶栓后第1小时D - 二聚体在链激酶组和尿激酶组中分别持续升高至269.4±206.7 nmol·L⁻¹和44.5±35.5 nmol·L⁻¹;P < 0.001。在两组均于5小时后达到峰值后,D - 二聚体在研究期间缓慢下降。仅链激酶组的21例患者中有10例恢复至正常水平;尿激酶组的20例患者中有14例在第3至6天恢复正常。在两组冠状动脉通畅TIMI 0或1级的患者停用静脉肝素后,D - 二聚体升高至正常水平的四至七倍;在两组冠状动脉血流TIMI 2或3级的患者中,D - 二聚体呈现单相性逐渐恢复正常的模式(TIMI 0 - 1组与TIMI 2 - 3组之间在第6天和第7天的差异分别为P < 0.05和P < 0.01)。心肌梗死后,溶栓后会出现活跃且持续的纤维蛋白降解,链激酶治疗后比尿激酶治疗后更明显且持续时间更长。较早发生时,这是溶栓剂诱导纤溶酶激活的结果;后期似乎与冠状动脉内底物有关,正如D - 二聚体血浆升高与梗死相关血管闭塞或次闭塞的存在之间的关系所提示的那样。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验